These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21103667)

  • 1. Clopidogrel withdrawal: is there a "rebound" phenomenon?
    Sambu N; Warner T; Curzen N
    Thromb Haemost; 2011 Feb; 105(2):211-20. PubMed ID: 21103667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
    Collet JP; Montalescot G; Steg PG; Steinhubl SR; Fox KA; Hu TF; Johnston SC; Hamm CW; Bhatt DL; Topol EJ
    Arch Cardiovasc Dis; 2009; 102(6-7):485-96. PubMed ID: 19664568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.
    Lemesle G; Torguson R; Bonello L; de Labriolle A; Maluenda G; Ben-Dor I; Collins SD; Syed AI; Xue Z; Satler LF; Pichard AD; Waksman R
    EuroIntervention; 2011 Apr; 6(9):1053-9. PubMed ID: 21518676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy in the perioperative period.
    Václavík J; Táborský M
    Eur J Intern Med; 2011 Feb; 22(1):26-31. PubMed ID: 21238889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID; Colombo A
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?
    Collet JP; Montalescot G
    Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prasugrel: Clinical development and therapeutic application.
    Guerra DR; Tcheng JE
    Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management.
    Reny JL; Bonvini RF; Bonvini JM; Roffi M; Fontana P
    Cardiovasc Ther; 2012 Feb; 30(1):e41-50. PubMed ID: 21073667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.
    Finkel JB; Marhefka GD; Weitz HH
    Hosp Pract (1995); 2013 Feb; 41(1):79-88. PubMed ID: 23466970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in responsiveness to oral antiplatelet therapy.
    Angiolillo DJ
    Am J Cardiol; 2009 Feb; 103(3 Suppl):27A-34A. PubMed ID: 19166710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence.
    Lordkipanidzé M; Diodati JG; Pharand C
    Pharmacol Ther; 2009 Aug; 123(2):178-86. PubMed ID: 19426760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel in acute coronary syndrome: implications of recent study findings.
    Duerschmied D; Bode C; Moser M
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1215-29. PubMed ID: 20828343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Bernlochner I; Steinhubl S; Braun S; Morath T; Jaitner J; Stegherr J; Mehilli J; von Beckerath N; Schömig A; Kastrati A; Sibbing D
    Thromb Haemost; 2010 Dec; 104(6):1193-200. PubMed ID: 20838744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
    Gurbel PA; Tantry US
    Thromb Haemost; 2011 Aug; 106(2):265-71. PubMed ID: 21713326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study.
    Sambu N; Dent H; Englyst N; Warner TD; Leadbeater P; Roderick P; Gray H; Simpson I; Corbett S; Calver A; Morgan J; Curzen N
    Heart; 2011 Oct; 97(20):1661-7. PubMed ID: 21795297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
    Terpening C
    J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.